NCT02957968 2025-08-28
Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast Ca
Virginia Commonwealth University
Phase 2 Active not recruiting
Virginia Commonwealth University
Shanghai Jiao Tong University School of Medicine
Dong Wha Pharmaceutical Co. Ltd.
Emory University
National Cancer Institute (NCI)